Cyrus Sayehli
- Oncology top 5%
- CAR-T cell therapy research 12
- Cancer Immunotherapy and Biomarkers 8
- Lung Cancer Research Studies 5
- Immunology top 10%
- Obstetrics and Gynecology top 10%
-
- Fibroblast Growth Factor Research 8
-
- Eosinophilic Disorders and Syndromes 6
-
- Radiopharmaceutical Chemistry and Applications 4
-
- Neuroendocrine Tumor Research Advances 4
-
- Bladder and Urothelial Cancer Treatments 4
Cyrus Sayehli
34 papers receiving 816 citations
Hit Papers
Peers
Comparison fields: 5 of 62
- Oncology 499
- Pathology and Forensic Medicine 231
- Immunology 245
- Genetics 78
- Obstetrics and Gynecology 56
Countries citing papers authored by Cyrus Sayehli
This map shows the geographic impact of Cyrus Sayehli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyrus Sayehli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyrus Sayehli more than expected).
Fields of papers citing papers by Cyrus Sayehli
This network shows the impact of papers produced by Cyrus Sayehli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyrus Sayehli. The network helps show where Cyrus Sayehli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cyrus Sayehli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 7 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 7 | |
| 9 | 2020 | 37 | |
| 10 | 2019 | 19 | |
| 11 | 2017 | 1 | |
| 12 | 2017 | 11 | |
| 13 | 2017 | 2 | |
| 14 | 2017 | 1 | |
| 15 | 2017 | 4 | |
| 16 | 2016 | 7 | |
| 17 | Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphomabreakdown → | 2016 | 280 |
| 18 | 2014 | 8 | |
| 19 | 2003 | 33 | |
| 20 | 2001 | 31 |
About Cyrus Sayehli
Cyrus Sayehli is a scholar working on Oncology, Genetics and Rheumatology, having authored 37 papers that have together received 831 indexed citations. Recurring topics across this work include CAR-T cell therapy research (12 papers), Fibroblast Growth Factor Research (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Eosinophilic Disorders and Syndromes (6 papers), Lung Cancer Research Studies (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Neuroendocrine Tumor Research Advances (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). The work is most often cited by research in Oncology (499 citations), Pathology and Forensic Medicine (231 citations) and Immunology (245 citations). Cyrus Sayehli has collaborated with scholars based in Germany, Spain and France. Frequent co-authors include Ralf C. Bargou, Michael Pfreundschuh, Nicole Adrian, Andreas Viardot, M. Libicher, Marie-Elisabeth Goebeler, Julia Stieglmaier, Florian Zettl, Alicia Zhang and Georg Heß. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.